Kansas City Personal Injury Attorney

816.298.8708
Call Today For A Free Consultation
Peterson & Associates, P.C.

Our Blog

Dilantin FDA Alert!

Mar 11, 2011

FDA ALERT:

FDA is investigating new preliminary data regarding a potential increased risk of serious skin reactions including Stevens Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) from phenytoin therapy in Asian patients positive for a particular human leukocyte antigen (HLA) allele, HLA-B*1502.

This allele occurs almost exclusively in patients with ancestry across broad areas of Asia, including Han Chinese, Filipinos, Malaysians, South Asian Indians, and Thais.

Because fosphenytoin is a pro drug and is converted to phenytoin after administration, any concern regarding this association is also applicable to fosphenytoin. Phenytoin and fosphenytoin are used to control tonic-clonic (grand mal) and complex-partial seizures in epilepsy. The FDA is working to identify additional information to evaluate the possible risk of SJS/TEN from phenytoin and fosphenytoin inpatients with HLA-B*1502. Until the evaluation is completed, healthcare providers who are considering the use of phenytoin or fosphenytoin should be aware of the risks and benefits described in the current prescribing information for this drug.

Peterson& Associates, P.C. is dedicated to help patients who have suffered injury from the use of Dilantin. If you or someone you know has suffered from Dilantin®, please contact us.

Categories: Dilantin

Contacting Our Kansas City Law Firm for a Free Consultation

Peterson & Associates, P.C. provides free consultations when you call or contact us online. Our law office is located in Kansas City, Missouri at:

Missouri’s Country Club Plaza 801 W. 47th Street, Suite 107, Kansas City MO 64112.

We do not charge our personal injury clients a fee unless their case is won, so there is no fee unless we win your case. Get in touch with us today as the first step in your pursuit of justice!

Injured? We Can Help You!

Fill out the form below for a free case evaluation.

  • Please enter your name.
  • This isn't a valid email address.
  • This isn't a valid phone number.
  • Please make a selection.
  • Please enter a message.